There was a consistent trend (but NS) of higher tumor MDCLR in unresponsive patients also when assessed in FFPE biopsies considering CD68+ for MDC and the sum of CD3+ (T lymphocytes) and CD20+ (B lymphocytes) for lymphocytes (Supplementary Fig. 11). This evidence concerns the gene CCL22 and neoplasm.